These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1416843)

  • 1. Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
    Tellier R; Krajden M; Grigoriew GA; Campbell I
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1619-25. PubMed ID: 1416843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.
    Hawser SP; Norris H; Jessup CJ; Ghannoum MA
    J Clin Microbiol; 1998 May; 36(5):1450-2. PubMed ID: 9574729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.
    Tsukatani T; Suenaga H; Shiga M; Matsumoto K
    Lett Appl Microbiol; 2014 Aug; 59(2):184-92. PubMed ID: 24713101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
    Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly JP; Verweij PE;
    J Clin Microbiol; 2001 Sep; 39(9):3402-8. PubMed ID: 11526191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination.
    Makimura K; Sudo T; Kudo M; Uchida K; Yamaguchi H
    Microbiol Immunol; 1998; 42(1):55-9. PubMed ID: 9525781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Barry AL
    J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.
    Hawser SP; Jessup C; Vitullo J; Ghannoum MA
    J Clin Microbiol; 2001 Jul; 39(7):2738-41. PubMed ID: 11427611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
    J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
    Odds FC; Vranckx L; Woestenborghs F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
    da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
    Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
    Touil HFZ; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
    van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC; Chang JJ; Huang AH; Chang TC
    J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Criteria for a microdilution susceptibility testing method of fluconazole: proposal of a standardized testing method for yeasts].
    Schmalreck AF; Fegeler W
    Mycoses; 1996; 39 Suppl 2():12-6. PubMed ID: 9198738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.